Imalia will present two abstracts at the 66th meeting of the American Society of Hematology:
•⁠ ⁠Title: IMA001 is a novel therapeutic molecule that reduces sickling and hemolytic anemia markers in a sickle cell disease mouse model
Format: Oral presentation
https://doi.org/10.1182/blood-2024-199612

•⁠ ⁠Title: IMA001 is a novel therapeutic molecule that improves hematological parameters during vaso-occlusion in sickle cell disease in vivo
Format: Poster
https://doi.org/10.1182/blood-2024-203501